Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

CMS announces billions in savings for Medicare when first and second rounds of negotiations go into effect in 2026 and 2027, ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The measure lowers prescription drug costs for seniors by empowering Medicare ...

Insurers are increasing rates as enhanced ACA premium tax credits, created in 2021, will soon sunset without congressional action. Without the boost, the income-based tax credits no longer will be ...

President Joe Biden speaks about his administration's plans to protect Social Security and Medicare and lower health care costs, Feb. 9, 2023, at the University of Tampa in Tampa, Fla. (AP ...

Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...

Jardiance is a medication doctors prescribe to treat heart failure and type 2 diabetes. Most Medicare Part D prescription drug plans include coverage for Jardiance. Part C plans with drug coverage ...

Some prices at the grocery store are still high despite the Bureau of Labor Statistics consumer price index remaining nearly flat in the last two months. Overall, grocery prices have increased nearly ...

Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $13.72 billion and ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price hikes, ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The ...